More than half of Aussie men report experiencing sexual difficulties

The Conversation, March 22, 2019

One in two Australian men aged 18 to 55 have experienced sexual difficulty in the past 12 months, according to data released this week.

The findings are drawn from the Australian Longitudinal Study on Male Health, which included more than 12,000 men. Overall, 54% of sexually active men reported having at least one specific sexual problem lasting three months or more.

The men reported a range of difficulties.

Transgender women taking PrEP have lower levels of PrEP drugs than cisgender men

aidsmap/nam, November 9th 2018

A study presented at October’s HIV Research for Prevention conference (HIVR4P) in Madrid shows that transgender women who are taking feminising hormones and also taking pre-exposure prophylaxis (PrEP) have levels of the PrEP drugs tenofovir and emtricitabine in their blood that are about 25% lower than those in cisgender men, and levels in rectal tissue cells about 40% lower. Tenofovir levels in rectal tissue were 44% lower.

However, the study also confirmed that the interaction between hormones and PrEP did not appear to go the other way; blood levels of estradiol, the one hormone all of the transgender women took in one form or another, do not appear to be affected by PrEP.